S. Biomedics Co, Ltd.
S. Biomedics was founded in 2003 and has been conducting stem cell therapy R&D since 2005, establishing itself as a leading stem cell therapy company in Korea. We have a total of 7 pipelines under development, with 4 in clinical trials. We have our own GMP-certified manufacturing facility, equipped with 8 production lines, and leverages over 10 years of experience in GMP facility operation, management, and quality assurance. We are a public company enlisted in the KOSDAQ Exchange as of June 2023.
